Tularemia presenting in a pregnant patient requires a carefully considered antimicrobial approach. Pregnancy constrains the use of many standard agents, making the selection of appropriate therapy a distinct clinical challenge.
This protocol applies to tularemia occurring in the context of pregnancy. The pregnant state directly influences which antimicrobial options can be safely used, and not all standard agents are suitable in this population.
When standard first-line and alternative antimicrobial options are unavailable or contraindicated, a specific alternative agent may be considered — but only when the infecting F. tularensis subspecies has been confirmed. The full criteria, agent selection, and clinical decision pathway are detailed in the complete protocol.
For pregnant women with any form of tularemia, fluoroquinolones (i.e., ciprofloxacin or levofloxacin) or gentamicin are recommended for first-line treatment.
In addition to the first-line and alternative treatment options, if supplies of these antimicrobial drugs are unavailable or patients have contraindications to these options, azithromycin 500 mg orally or IV for 10 days can be considered if the pathogen released is known to be F. tularensis subspecies tularensis (Type A) or F. tularensis subspecies holarctica (Type B) biovar I or biovar japonica.
View source ↗